Activité de trading des initiés

Comments

Scholar Rock Holding Activité de délit d'initié

SRRKNASDAQ

Logo présenté par Benzinga Data

Commerce avec le public

$46.05

1.312.93%

À la clôture: Jan 21, 4:00 PM EST

$46.05

N/A

Après les heures: 4:28 PM EST

Aperçu Actualités Gains Options Évaluations des analystes

Transactions internes

Intérêt court Rapport sur les stocks

Activité de trading des initiés

Suivez les dernières activités de délit d'initié Scholar Rock Holding. Restez informé des achats, des ventes et de l'impact sur le marché des actions Scholar Rock Holding.

Qu’est-ce que l’activité d’initié ?

L'activité de délit d'initié implique des initiés de l'entreprise, tels que des dirigeants, des administrateurs et des employés, qui s'engagent dans des transactions sur les actions de leur propre entreprise. Les transactions d'achat et de vente des initiés fournissent des informations précieuses sur leur confiance dans les performances futures de l'entreprise.

Que font les Scholar Rock Holding Corp Insiders ?

À Scholar Rock Holding Corp, une activité interne récente a attiré l'attention. Au cours des 30 derniers jours, les initiés ont déclaré avoir vendu un total de 140.21K actions d'une valeur de $6.04M. ne signalez aucun achat au cours des 30 derniers jours.

Achats et ventes récents notables d’initiés

Le décembre 16, 2025 Srinivas Akkaraju, le - purchased 1.09M actions pour $8.23 chacune.
Le décembre 18, 2025 Katie Peng, le - sold 1.01K actions pour $44.09 chacune.
Le janvier 21, 2026 Jing L Marantz, le CHIEF MEDICAL OFFICER sold 5.8K actions pour $44.48 chacune.

Statistiques de propriété pour Scholar Rock Holding Corp

Actions en circulation

102.007M

Actions détenues par les initiés

8.686M

Pourcentage d'actions détenu par les initiés

8.51%

Actions détenues par les institutions

66.487M

Pourcentage d'actions détenu par les institutions

65.2%


Jan 21, 2026	Mo Qatanani	CHIEF SCIENTIFIC OFFICER	-8.41K	$44.48	-$373.88K	SELL	-7.71%	100.56K	Jan 16	View
Jan 21, 2026	Caryn Parlavecchio	CHRO	-6.60K	$44.48	-$293.55K	SELL	-4.25%	148.86K	Jan 16	View
Jan 21, 2026	Jing L Marantz	CHIEF MEDICAL OFFICER	-5.80K	$44.48	-$257.88K	SELL	-5.71%	95.69K	Jan 16	View
Jan 21, 2026	Junlin Ho	GENERAL COUNSEL	-8.02K	$44.48	-$356.53K	SELL	-3.60%	214.55K	Jan 16	View
Jan 16, 2026	Mo Qatanani	CHIEF SCIENTIFIC OFFICER	0.00	$31.86	-$349.65K	SELL-OPTIONS	0.00%	108.96K	Jan 14	View
Jan 15, 2026	Vikas Sinha	CHIEF FINANCIAL OFFICER	-16.75K	$42.70	-$715.44K	SELL	-2.79%	583.25K	Jan 13	View
Jan 15, 2026	Keith Woods	CHIEF OPERATING OFFICER	-16.75K	$42.70	-$715.05K	SELL	-2.79%	583.25K	Jan 13	View
Jan 15, 2026	Akshay Vaishnaw	PRESIDENT R&D	-20.44K	$42.70	-$872.70K	SELL	-3.32%	595.77K	Jan 13	View
Jan 15, 2026	David Hallal	CHIEF EXECUTIVE OFFICER	-57.45K	$42.70	-$2.45M	SELL	-3.18%	1.75M	Jan 13	View
Dec 18, 2025	Katie Peng	—	-1.01K	$44.09	-$44.35K	SELL	-2.97%	32.91K	Dec 16	View
Dec 16, 2025	Srinivas Akkaraju	—	1.09M	$8.23	$9.01M	BUY	20.67%	6.39M	Oct 07 - Dec 12	View
Dec 05, 2025	Mo Qatanani	CHIEF SCIENTIFIC OFFICER	0.00	$33.21	-$3.28M	SELL-OPTIONS	0.00%	108.96K	Dec 04	View
Oct 07, 2025	Srinivas Akkaraju	—	500.44K	$37.58	$18.81M	BUY	9.44%	5.80M	Oct 03 - Oct 06	View
Sep 24, 2025	Mo Qatanani	CHIEF SCIENTIFIC OFFICER	-3.35K	$30.67	-$102.85K	SELL	-2.99%	108.96K	Sep 22	View
Sep 17, 2025	Katie Peng	—	-1.01K	$32.53	-$32.73K	SELL	-2.88%	33.91K	Sep 16	View
Sep 17, 2025	Mo Qatanani	CHIEF SCIENTIFIC OFFICER	-3.18K	$33.52	-$106.53K	SELL	-2.75%	112.32K	Sep 16	View
Aug 19, 2025	Caryn Parlavecchio	CHRO	-2.18K	$31.17	-$67.88K	SELL	-1.38%	155.46K	Aug 18	View
Jul 18, 2025	Jeffrey S Flier	—	-11.14K	$40.02	-$445.69K	SELL	-31.63%	24.07K	Jul 16	View
Jul 10, 2025	Mo Qatanani	CHIEF SCIENTIFIC OFFICER	-24.07K	$34.44	-$828.90K	SELL	-17.24%	115.50K	Jul 08	View
Jun 25, 2025	Jeffrey S Flier	—	-11.14K	$27.10	-$585.49K	SELL	-50.00%	11.14K	Jun 23	View
Jun 17, 2025	Katie Peng	—	-3.03K	$31.97	-$96.89K	SELL	-7.99%	34.92K	Jun 16	View
Jun 17, 2025	Mo Qatanani	CHIEF SCIENTIFIC OFFICER	-3.67K	$32.00	-$117.38K	SELL	-2.56%	139.56K	Jun 16	View
Jun 17, 2025	Caryn Parlavecchio	CHRO	-6.19K	$32.00	-$197.96K	SELL	-3.78%	157.64K	Jun 16	View
Jun 17, 2025	Junlin Ho	GENERAL COUNSEL	-7.44K	$32.00	-$238.15K	SELL	-3.24%	222.57K	Jun 16	View
May 30, 2025	Jeffrey S Flier	—	-6.08K	$29.73	-$180.58K	SELL	-11.59%	46.34K	May 29	View
May 30, 2025	Kristina Burow	—	-5.40K	$29.72	-$160.51K	SELL	-0.23%	2.37M	May 29	View
May 30, 2025	Michael Gilman	—	-3.38K	$29.72	-$100.30K	SELL	-5.76%	55.22K	May 29	View
May 30, 2025	Richard Brudnick	—	-6.08K	$29.72	-$180.53K	SELL	-28.75%	15.06K	May 29	View
May 30, 2025	Joshua Reed	—	-5.40K	$29.72	-$160.46K	SELL	-25.55%	15.73K	May 29	View
May 30, 2025	Akshay Vaishnaw	PRESIDENT R&D	-6.75K	$29.72	-$200.61K	SELL	-1.08%	616.21K	May 29	View
Apr 29, 2025	Tracey Sacco	CHIEF COMMERCIAL OFFICER	0.00	$21.41	-$114.13K	SELL-OPTIONS	0.00%	71.75K	Apr 25	View
Mar 25, 2025	Tracey Sacco	CHIEF COMMERCIAL OFFICER	-1.50K	$21.54	-$165.01K	SELL	-2.05%	71.75K	Mar 24	View
Mar 25, 2025	Erin Moore	INTERIM PFO AND PAO	0.00	$25.23	-$214.15K	SELL-OPTIONS	0.00%	82.61K	Mar 24	View
Mar 19, 2025	Katie Peng	—	-1.01K	$34.42	-$34.63K	SELL	-3.21%	30.32K	Mar 17	View
Mar 12, 2025	Edward H Myles	COO & CFO	-29.39K	$24.61	-$3.53M	SELL	-20.89%	111.34K	Mar 10	View
Feb 20, 2025	Mo Qatanani	CHIEF SCIENTIFIC OFFICER	-24.34K	$23.78	-$2.22M	SELL	-17.97%	111.08K	Feb 18 - Feb 19	View
Feb 20, 2025	Caryn Parlavecchio	CHRO	-5.30K	$36.83	-$195.05K	SELL	-3.64%	140.26K	Feb 18	View
Feb 20, 2025	Edward H Myles	COO & CFO	-7.81K	$36.83	-$287.60K	SELL	-5.26%	140.74K	Feb 18	View
Feb 20, 2025	Junlin Ho	GENERAL COUNSEL	-5.74K	$36.83	-$211.47K	SELL	-2.94%	189.29K	Feb 18	View
Feb 20, 2025	Jay T Backstrom	CHIEF EXECUTIVE OFFICER	-18.37K	$36.83	-$676.62K	SELL	-5.56%	311.99K	Feb 18	View
Jan 21, 2025	Jay T Backstrom	CHIEF EXECUTIVE OFFICER	-22.31K	$44.20	-$985.95K	SELL	-6.33%	330.36K	Jan 16	View
Jan 21, 2025	Jing Marantz	CHIEF MEDICAL OFFICER	-5.66K	$44.20	-$249.94K	SELL	-7.76%	67.20K	Jan 16	View
Jan 21, 2025	Tracey Sacco	CHIEF COMMERCIAL OFFICER	-3.89K	$44.20	-$171.93K	SELL	-7.89%	45.40K	Jan 16	View
Jan 21, 2025	Mo Qatanani	CHIEF SCIENTIFIC OFFICER	-7.35K	$44.20	-$324.72K	SELL	-5.15%	135.42K	Jan 16	View
Jan 21, 2025	Caryn Parlavecchio	CHRO	-6.43K	$44.20	-$284.36K	SELL	-4.23%	145.55K	Jan 16	View
Jan 21, 2025	Edward H Myles	COO & CFO	-12.54K	$44.20	-$554.19K	SELL	-7.78%	148.55K	Jan 16	View
Jan 21, 2025	Junlin Ho	GENERAL COUNSEL	-9.04K	$44.20	-$399.50K	SELL	-4.43%	195.04K	Jan 16	View
Dec 12, 2024	Invus Public Equities LP Invus Public Equities Advisors LLC Siren LLC Invus Global Management LLC RAYMOND DEBBANE	—	-1.60M	$41.65	-$66.64M	SELL	-14.75%	9.25M	Dec 10	View
Nov 27, 2024	Invus Public Equities LP Invus Public Equities Advisors LLC Siren LLC Invus Global Management LLC RAYMOND DEBBANE	—	-409.43K	$38.49	-$15.76M	SELL	-3.64%	10.85M	Nov 25	View
Nov 26, 2024	Jing L Marantz	CHIEF MEDICAL OFFICER	0.00	$22.83	-$242.58K	SELL-OPTIONS	0.00%	72.86K	Nov 22 - Nov 25	View
Nov 13, 2024	Jing L Marantz	CHIEF MEDICAL OFFICER	0.00	$19.30	-$45.08K	SELL-OPTIONS	0.00%	72.86K	Nov 11	View
Oct 10, 2024	Edward H Myles	COO & CFO	0.00	$22.45	-$925.79K	SELL-OPTIONS	0.00%	161.09K	Oct 08	View
Oct 07, 2024	Edward H Myles	COO & CFO	-412.48K	$20.19	-$8.33M	SELL	-71.91%	161.09K	Oct 07	View
Oct 07, 2024	Tracey Sacco	CHIEF COMMERCIAL OFFICER	0.00	$17.81	-$468.68K	SELL-OPTIONS	0.00%	49.28K	Oct 07	View
Oct 07, 2024	Srinivas Akkaraju	—	-1.18M	$29.25	-$34.39M	SELL	-17.28%	5.63M	Oct 07	View
Oct 07, 2024	Jing L Marantz	CHIEF MEDICAL OFFICER	0.00	$17.90	-$2.04M	SELL-OPTIONS	0.00%	72.86K	Oct 07	View
Sep 19, 2024	Mo Qatanani	CHIEF SCIENTIFIC OFFICER	-1.94K	$8.58	-$16.61K	SELL	-1.34%	142.77K	Sep 16	View
Aug 19, 2024	Caryn Parlavecchio	CHRO	-1.45K	$9.33	-$13.54K	SELL	-0.95%	151.99K	Aug 16	View
Jun 18, 2024	Mo Qatanani	CHIEF SCIENTIFIC OFFICER	-2.31K	$8.98	-$20.80K	SELL	-1.57%	144.70K	Jun 17	View
Jun 18, 2024	Caryn Parlavecchio	CHRO	-4.30K	$8.98	-$38.68K	SELL	-2.73%	153.44K	Jun 17	View
Jun 18, 2024	Edward H Myles	COO & CFO	-9.46K	$8.98	-$84.98K	SELL	-4.48%	201.52K	Jun 17	View
Jun 18, 2024	Junlin Ho	GENERAL COUNSEL	-4.70K	$8.98	-$42.18K	SELL	-2.25%	204.08K	Jun 17	View
Feb 21, 2024	Edward H Myles	COO & CFO	-4.74K	$15.74	-$74.69K	SELL	-2.20%	210.98K	Feb 16	View
Feb 20, 2024	Mo Qatanani	CHIEF SCIENTIFIC OFFICER	-2.51K	$15.74	-$39.55K	SELL	-1.68%	147.02K	Feb 16	View
Feb 20, 2024	Caryn Parlavecchio	CHRO	-3.75K	$15.74	-$59.05K	SELL	-2.32%	157.74K	Feb 16	View
Feb 20, 2024	Junlin Ho	GENERAL COUNSEL	-3.49K	$15.74	-$54.93K	SELL	-1.64%	208.77K	Feb 16	View
Feb 20, 2024	Jay T Backstrom	CHIEF EXECUTIVE OFFICER	-11.61K	$15.74	-$182.84K	SELL	-3.19%	352.67K	Feb 16	View
Jan 18, 2024	Mo Qatanani	SVP AND HEAD OF RESEARCH	-2.00K	$15.93	-$31.89K	SELL	-2.48%	78.82K	Jan 16	View
Jan 18, 2024	Caryn Parlavecchio	CHRO	-2.85K	$15.93	-$45.38K	SELL	-2.43%	114.35K	Jan 16	View
Jan 18, 2024	Edward H Myles	COO & CFO	-6.63K	$15.93	-$105.67K	SELL	-3.93%	162.15K	Jan 16	View
Jan 18, 2024	Junlin Ho	GENERAL COUNSEL	-4.19K	$15.93	-$66.68K	SELL	-2.64%	154.41K	Jan 16	View
Dec 29, 2023	Edward H Myles	COO & CFO	0.00	$11.85	-$174.08K	SELL-OPTIONS	0.00%	168.78K	Dec 29	View
Dec 15, 2023	Mo Qatanani	SVP AND HEAD OF RESEARCH	-16.23K	$14.09	-$364.07K	SELL	-16.72%	80.82K	Dec 14	View
Dec 08, 2023	Edward H Myles	COO & CFO	0.00	$11.20	-$315.74K	SELL-OPTIONS	0.00%	168.78K	Dec 07	View
Nov 03, 2023	Edward H Myles	COO & CFO	-35.01K	$12.51	-$438.04K	SELL	-17.18%	168.78K	Nov 02	View
Oct 18, 2023	Srinivas Akkaraju	DIRECTOR	2.19M	$6.85	$15.00M	BUY	47.62%	6.79M	Oct 16	View
Oct 18, 2023	Samsara BioCapital GP LLC Samsara BioCapital LP	10% OWNER	2.19M	$6.85	$15.00M	BUY	47.62%	6.79M	Oct 16	View
Oct 16, 2023	Invus Public Equities LP Artal International SCA Artal International Management SA SA Group Artal SA Westend Westend Administratiekantoor Stichting Amaury Wittouck Invus Public Equities Advisors LLC	—	2.20M	$6.86	$15.09M	BUY	24.28%	11.26M	Oct 12	View
Sep 20, 2023	Mo Qatanani	SVP AND HEAD OF RESEARCH	-1.95K	$6.34	-$12.33K	SELL	-1.96%	97.04K	Sep 18	View
Aug 18, 2023	Caryn Parlavecchio	CHRO	-1.35K	$6.83	-$9.24K	SELL	-1.14%	117.20K	Aug 16	View
May 02, 2023	Invus Public Equities LP Artal International SCA Artal International Management SA SA Group Artal SA Westend Amaury Wittouck Westend Administratiekantoor Stichting Invus Public Equities Advisors LLC	10% OWNER	31.56K	$6.43	$202.85K	BUY	0.35%	9.06M	Apr 28	View
Jan 11, 2023	Invus Public Equities LP Artal International SCA Artal International Management SA SA Group Artal SA Westend Westend Administratiekantoor Stichting Amaury Wittouck Invus Public Equities Advisors LLC	10% OWNER	-1.09K	$9.48	-$10.37K	SELL	-0.01%	9.03M	Jan 09	View
Jan 09, 2023	Invus Public Equities LP Artal International SCA Artal International Management SA SA Group Artal SA Westend Westend Administratiekantoor Stichting Amaury Wittouck Invus Public Equities Advisors LLC	10% OWNER	48.77K	$9.33	$455.09K	BUY	0.54%	9.03M	Jan 05	View
Oct 27, 2022	Invus Public Equities LP Artal International SCA Artal International Management SA SA Group Artal SA Westend Westend Administratiekantoor Stichting Amaury Wittouck Invus Public Equities Advisors LLC	10% OWNER	130.26K	$8.04	$1.05M	BUY	1.47%	8.98M	Oct 25	View
Oct 07, 2022	Invus Public Equities LP Artal International SCA Artal International Management SA SA Group Artal SA Westend Westend Administratiekantoor Stichting Amaury Wittouck Invus Public Equities Advisors LLC	10% OWNER	99.97K	$7.60	$759.55K	BUY	1.14%	8.85M	Oct 03 - Oct 04	View
Jun 24, 2022	Amir Nashat	DIRECTOR	1.20M	$4.90	$5.87M	BUY	∞	214.34K	Jun 22	View
Nov 15, 2021	Edward H Myles	CHIEF FINANCIAL OFFICER	0.00	$35.14	-$2.75M	SELL-OPTIONS	0.00%	24.15K	Nov 11 - Nov 15	View
Oct 05, 2021	Jeffrey S Flier	DIRECTOR	-6.00K	$30.89	-$185.33K	SELL	-21.22%	22.27K	Oct 01	View
Sep 21, 2021	Jeffrey S Flier	DIRECTOR	-500.00	$34.09	-$17.05K	SELL	-5.26%	9.01K	Sep 20	View
Jul 28, 2021	Jeffrey S Flier	DIRECTOR	-6.00K	$31.66	-$189.95K	SELL	-17.51%	28.27K	Jul 26	View
Mar 17, 2021	Michael Gilman	DIRECTOR	-4.70K	$65.59	-$308.00K	SELL	-11.14%	37.46K	Mar 15	View
Feb 11, 2021	Michael Gilman	DIRECTOR	-1.80K	$65.06	-$117.36K	SELL	-4.10%	42.16K	Feb 08	View
Jan 28, 2021	Michael Gilman	DIRECTOR	0.00	$32.51	-$187.27K	SELL-OPTIONS	0.00%	43.96K	Jan 26	View
Jan 28, 2021	Gregory J. Carven	HEAD RESEARCH	-18.36K	$34.20	-$2.89M	SELL	-40.59%	26.86K	Jan 26 - Jan 27	View
May 31, 2018	Polaris Venture Management Co VI LLC Polaris Venture Partners VI LP Polaris Venture Partners Founders Fund VI LP	10% OWNER	2.83M	$14.00	$2.00M	BUY	∞	156.40K	May 29	View
May 31, 2018	Amir Nashat	DIRECTOR	2.83M	$14.00	$2.00M	BUY	∞	156.40K	May 29	View
May 31, 2018	SCA International Artal Invus Public Equities LP Invus Public Equities Advisors LLC SA Management International Artal SA Group Artal SA Westend Westend Administratiekantoor Stichting Pascal Minne	10% OWNER	2.40M	$14.00	$6.30M	BUY	∞	450.00K	May 29	View
May 31, 2018	Timothy Springer	DIRECTOR	2.76M	$14.00	$999.99K	BUY	∞	275.90K	May 29	View

FAQ

Est-ce que le trading d'initiés est légal ?

Le trading d'initiés est légal tant que les initiés signalent ces transactions à la SEC. Le trading de titres illégal se produit lorsque l'initié enfreint un devoir fiduciaire ou omet de signaler ses transactions.

Quels sont quelques exemples de manipulation de marché ?

Le trading d'initiés, les schémas de gonflement et de vidage, le front running et les opérations de lavage sont tous des exemples de manipulation de marché. Les investisseurs qui suivent les mouvements d'actifs des initiés devraient réfléchir attentivement à la raison pour laquelle ces initiés échangent leurs actions avant de passer à l'action.

Parcourir transactions d'initiés sur toutes les actions.